12.07.2015 Views

Familial Nasopharyngeal Carcinoma 6

Familial Nasopharyngeal Carcinoma 6

Familial Nasopharyngeal Carcinoma 6

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

294 S. S. Lo, J. J. Lu, and L. KongSt Clair WH, Arnold SM, Sloan AE, et al (2003) Spinal cord andperipheral nerve injury: current management and investigations.Semin Radiat Oncol 13(3):322–332Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE,Jardine JH (1986) Unique radiosensitivity of serous cells inrhesus monkey submandibular glands. Am J Pathol124(3):479–487Stinson SF, DeLaney TF, Greenberg J, et al (1991) Acute andlong-term effects on limb function of combined modalitylimb sparing therapy for extremity soft tissue sarcoma. IntJ Radiat Oncol Biol Phys 21(6):1493–1499Stoll BA, Andrews JT (1966) Radiation-induced peripheralneuropathy. Br Med J 1:834–837Stryker JA, Sommerville K, Perez R, Velkley DE (1990) Sacralplexus injury after radiotherapy for carcinoma of cervix.Cancer 66(7):1488–1492Sultanem K, Shu HK, Xia P, et al (2000) Three-dimensional intensity-modulatedradiotherapy in the treatment of nasopharyngealcarcinoma: the University of California-San Franciscoexperience. Int J Radiat Oncol Biol Phys 48(3):711–722Trotti A, Colevas AD, Setser A, et al (2003) CTCAE v3.0: developmentof a comprehensive grading system for the adverseeffects of cancer treatment. Semin Radiat Oncol 13(3):176–181Vacha P, Fehlauer F, Mahlmann B, et al (2003) Randomizedphase III trial of postoperative radiochemotherapy +/-amifostine in head and neck cancer. Is there evidence forradioprotection? Strahlenther Onkol 179(6):385–389van Oijen MG, Leppers Vd Straat FG, Tilanus MG, Slootweg PJ(2000) The origins of multiple squamous cell carcinomasin the aerodigestive tract. Cancer 88(4):884–893Wang X, Lu JJ, Xiong X, et al (2009) Anatomic and dosimetricchanges during the treatment course of intensity-modulatedradiotherapy for locally advanced nasopharyngealcarcinoma? Med DosimWarde P, O’Sullivan B, Aslanidis J, et al (2002) A Phase III placebo-controlledtrial of oral pilocarpine in patients undergoingradiotherapy for head-and-neck cancer. Int J RadiatOncol Biol Phys 54(1):9–13Wee J, Tan EH, Tai BC, et al (2005) Randomized trial of radiotherapyversus concurrent chemoradiotherapy followed byadjuvant chemotherapy in patients with American JointCommittee on Cancer/International Union against cancerstage III and IV nasopharyngeal cancer of the endemicvariety. J Clin Oncol 23(27):6730–6738Wescott WB, Mira JG, Starcke EN, Shannon IL, Thornby JI (1978)Alterations in whole saliva flow rate induced by fractionatedradiotherapy. AJR Am J Roentgenol 130(1): 145–149Yamamoto E, Shibuya H, Yoshimura R (2002) Miura M. Sitespecific dependency of second primary cancer in earlystage head and neck squamous cell carcinoma. Cancer94(7):2007–2014Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY (2005) Treatmentoutcomes and late complications of 849 patients withnasopharyngeal carcinoma treated with radiotherapyalone. Int J Radiat Oncol Biol Phys 62(3):672–679

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!